Illumina (ILMN) Beats Q3 Earnings Estimates, Raises View
Illumina, Inc.’s ILMN third-quarter 2019 adjusted earnings per share (EPS) of $1.93 surpassed the Zacks Consensus Estimate by 37.9%. Moreover, the bottom line improved 26.9% from the year-ago quarter’s figure.
Including one-time items, the company reported EPS of $1.58, up 18.8% year over year.
Revenues
In the quarter under review, Illumina’s revenues rose 6.3% year over year to $907 million. The top line also surpassed the Zacks Consensus Estimate by 4%. The year-over-year growth can be attributed to the company’s collaborations to develop distributable clinical IVDs for Illumina sequencers.
...
https://finance.yahoo.com/news/illumina-...01269.html
Illumina, Inc.’s ILMN third-quarter 2019 adjusted earnings per share (EPS) of $1.93 surpassed the Zacks Consensus Estimate by 37.9%. Moreover, the bottom line improved 26.9% from the year-ago quarter’s figure.
Including one-time items, the company reported EPS of $1.58, up 18.8% year over year.
Revenues
In the quarter under review, Illumina’s revenues rose 6.3% year over year to $907 million. The top line also surpassed the Zacks Consensus Estimate by 4%. The year-over-year growth can be attributed to the company’s collaborations to develop distributable clinical IVDs for Illumina sequencers.
...
https://finance.yahoo.com/news/illumina-...01269.html
![[Bild: ILMNc1dl1533.png]](https://finviz.com/publish/102519/ILMNc1dl1533.png)
__________________